Wanna know why Big Pharma is Knocking on This French Startup's Door? Listen to this!More #water insights? Connect with me on Linkedin: https://www.linkedin.com/in/antoinewalter1/ Supporters A big thank you to my partner SimpleLab: https://link.dww.show/simplelabAnd a great shout-out to Blue Foot Membranes: https://link.dww.show/bluefoot#️⃣ All the Links Mentioned in this Video #️⃣Diamidex's crowdfunding campaign: https://www.invesdor.com/rounds/0cd04be7-da71-4b8f-be26-6a778d2648dd?utm_campaign=c.diamidex_nr1.ex&utm_source=website&utm_medium=referral#/The 2022 Nobel Prize they leverage in their technology: https://www.nobelprize.org/uploads/2022/10/press-chemistryprize2022-2.pdfDiamidex's website: https://diamidex.com/Connect with Sam on LinkedIn: https://www.linkedin.com/in/sam-dukan/️ Subscribe and Listen to the Don't Waste Water Podcast HERE ️Podcast Channel: @dwwpodcast Main Channel: @AntoineWalterDWW Smartlink: https://smartlink.ausha.co/dont-waste-waterWebsite: https://dww.show/podcast/ QUESTION: What would you like me to cover next?⏰ TIME CODES ⏰00:00 In this week's Episode01:31 Should you invest in Diamidex?03:34 Technological Breakthroughs in Microbial Detection11:11 Development Journey and Challenges20:21 Product Launch and Market Feedback28:21 Future Prospects and Innovations32:38 Addressing the Elephant in the Room: Regulation35:57 Global Adoption and Market Strategies47:24 Business Model and Revenue Streams53:56 Future Vision and Growth Strategies59:33 Rapid Fire Questions and Closing Remarks IN THIS WEEK'S EPISODE How a 10-year journey from CNRS research director to water tech entrepreneur led to a breakthrough that counts microorganisms 4-7x faster than century-old Petri dish methods Why this technology delivers results in 6 hours for E. coli instead of 24 hours and 2 days for Legionella instead of 10 days, while maintaining exact regulatory compliance The secret sauce combining optics, click chemistry (Nobel Prize 2022), and machine learning that makes invisible microbes visible and countable at the micro-colony stage How major pharmaceutical and beverage companies are knocking on Diamidex's door, with one global partnership launching end of 2024 and acquisition talks already underway The razor-blade business model targeting 75-80% recurring revenue from consumables, with equipment potentially given free to high-volume customers, generating €500K annuallyHosted on Ausha. See ausha.co/privacy-policy for more information.